Additionally, we found that attenuated tumor growth in LEC MHC-II knockout background was associated with an overall improved tumor-specific immune response as characterized by increased numbers of tumor-specific CD8+ and effector CD4+ T cells, as well as decreased numbers of Tregs locally. The gene discussed is CD8A; the disease is neoplasm.